Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-25 @ 1:50 PM
Study NCT ID:
NCT02321592
Status:
COMPLETED
Last Update Posted:
2020-11-13
First Post:
2014-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
University of Cologne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-17
First Submit QC Date:
None
Study First Post Date:
2014-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-11
Last Update Post Date:
2020-11-13
Last Update Post Date Type:
ACTUAL